RiverFront Investment Group’s Colgate-Palmolive CL Stock Holding History

RiverFront Investment Group’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$746K	Buy	8,747 +1,672	+24%	+$149K	0.01%	226
2025 Q4	$559K	Buy	7,075 +2,459	+53%	+$193K	0.01%	221
2025 Q3	$369K	Buy	4,616 +378	+9%	+$32.2K	0.01%	240
2025 Q2	$385K	Buy	4,238 +843	+25%	+$77K	0.01%	228
2025 Q1	$318K	Buy	+3,395	New	+$304K	0.01%	229
2014 Q2	–	Sell	-273,098	Closed	-$17.7M	–	88
2014 Q1	$17.7M	Buy	273,098 +8,990	+3%	+$567K	0.47%	46
2013 Q4	$17.2M	Buy	+264,108	New	+$16.9M	0.5%	42

Other funds holding CL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

RiverFront Investment Group's CL Position: Q1 2026 in Review

RiverFront Investment Group increased its Colgate-Palmolive (CL) stake by 24% in Q1 2026, buying an estimated $149K and bringing the position to 8,747 shares worth $746K. The position accounts for 0.01% of the portfolio, ranked #226.

RiverFront Investment Group first reported a position in CL in Q4 2013 and has held it in 7 quarters since. The position peaked at $17.7M in Q1 2014. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

RiverFront Investment Group held 8,747 shares of Colgate-Palmolive worth $746K as of Q1 2026.
RiverFront Investment Group bought 1,672 Colgate-Palmolive shares in Q1 2026, an estimated $149K.
Colgate-Palmolive made up 0.01% of RiverFront Investment Group's portfolio in Q1 2026, its #226 holding.
RiverFront Investment Group first reported a position in Colgate-Palmolive in Q4 2013 and has held it in 7 quarters since.
RiverFront Investment Group's Colgate-Palmolive position peaked at $17.7M in Q1 2014.
1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on RiverFront Investment Group's 13F filing for Q1 2026, filed 11 May 2026.